Clinical Trial Detail

NCT ID NCT02609984
Title Trial of CMB305 and Atezolizumab in Patients With Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Immune Design
Indications

myxoid liposarcoma

synovial sarcoma

Therapies

Atezolizumab

G305 + ID-LV305

Age Groups: adult

No variant requirements are available.